KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Net Income: 2009-2025

Historic Net Income for Colgate Palmolive (CL) over the last 17 years, with Sep 2025 value amounting to $766.0 million.

  • Colgate Palmolive's Net Income fell 1.29% to $766.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 0.40%. This contributed to the annual value of $3.0 billion for FY2024, which is 24.20% up from last year.
  • Colgate Palmolive's Net Income amounted to $766.0 million in Q3 2025, which was down 0.91% from $773.0 million recorded in Q2 2025.
  • Colgate Palmolive's Net Income's 5-year high stood at $779.0 million during Q4 2024, with a 5-year trough of $43.0 million in Q4 2022.
  • Over the past 3 years, Colgate Palmolive's median Net Income value was $760.0 million (recorded in 2023), while the average stood at $706.5 million.
  • Its Net Income has fluctuated over the past 5 years, first tumbled by 77.13% in 2022, then spiked by 1,667.44% in 2023.
  • Quarterly analysis of 5 years shows Colgate Palmolive's Net Income stood at $188.0 million in 2021, then slumped by 77.13% to $43.0 million in 2022, then spiked by 1,667.44% to $760.0 million in 2023, then rose by 2.50% to $779.0 million in 2024, then declined by 1.29% to $766.0 million in 2025.
  • Its last three reported values are $766.0 million in Q3 2025, $773.0 million for Q2 2025, and $726.0 million during Q1 2025.